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Objective: This study aimed to identify the key intracellular pattern recognition receptor (PRR) and its
role in the unbalanced extracellular matrix gene expressions of chondrocytes treated by T-2 toxin, a
potential etiological factor for cartilage damages.
Design: Differential expressions of intracellular PRRs after T-2 toxin treatment were screened by RT-qPCR
in chondrocytes. RNAi was used to knockdown the expression of NOD2 and its two downstream signal
molecules, RIPK2, and TBK1, for observing the effects of NOD2 pathway on regulation of metabolism gene
expressions by RT-qPCR. The matrix metalloproteinases (MMP) activity was determined by gelatin
zymography. The inhibitor of NF-kB and ROS scavenger were exploited to analyze the mechanism of
NOD2 up-regulation in chondrocytes treated with T-2 toxin.
Results: In chondrocytes treated with T-2 toxin, anabolism genes were down-regulated whereas
catabolism genes were up-regulated, and NOD2 was identiﬁed as a signiﬁcantly up-regulated gene.
Intervening NOD2 expression via RNAi could ameliorate the down-regulation of anabolism genes, while
inhibit the up-regulation of catablolism genes induced by T-2 toxin in chondrocytes. RNAi of RIPK2 and
TBK1 in chondrocytes could obtain the similar outcome. Furthermore, up-regulation of NOD2 expression
induced by T-2 toxin could be abrogated by pretreating the cells with inhibitors of NF-kB and scavenger
of ROS.
Conclusion: T-2 toxin could up-regulate NOD2 expression via ROS/NF-kB pathway and activate NOD2
signaling pathway. The up-regulated NOD2 would affect the metabolism gene expressions and MMP
activity in chondrocytes via RIPK2 and TBK1. The ﬁndings add new insights into understanding NOD2
effects on chondrocytes treated with T-2 toxin.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.o: L. Meng, Department of
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Osteoarthritis (OA) is one of the mostly common degenerative
disorders, and characterized by obvious detrimental cartilage
remodeling1,2. In the normal scenario, extracellular matrix (ECM) in
cartilage maintains a balance between anabolism and catabolism.
But during OA including a secondary OA, Kashin-Beck disease
(KBD), the balance is destroyed and the catabolism genes are up-
regulated in articular cartilage. The diverse factors such as proin-
ﬂammatory cytokines3, ﬁbronectin fragments4 and bacterial li-
gands5 are involved in cartilage destruction. Among these factors,
the inﬂammatory cytokines and proteases of ECM act as the main
players in ECM degradation and remodeling process2. Importantly,td. All rights reserved.
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matrix metalloproteinases (MMPs) in chondrocytes6. The recent
ﬁndings indicate that both interleukine-1(IL-1) and tumor necrosis
factor a (TNF-a) can induce themRNA expression and the activation
of MMP1, MMP3 and MMP13 in human articular chondrocytes, and
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
kB) and c-Jun N-terminal kinase (JNK) signaling may be involved in
this process7. As is well-known, the great progress has been ach-
ieved in the association of pattern recognition receptors (PRR) with
inﬂammation. Hence close attention has been recently drawn to
the role of PRR in the development of OA.
PRRs are constitutively expressed in the innate immunocytes
and other resident cells and exert the function by recognizing
pathogen-associated molecular patterns (PAMPs) of microorgan-
isms and also damage-associatedmolecular patterns (DAMPs) from
destroyed or necrotic cells8. Recent studies have documented that
PRRs actively participate in OA development. The polymorphisms
of toll like receptor (TLR) 3 and TLR9 in human are associated with
knee OA9,10. The expressions of TLR1 and TLR2 are up-regulated in
OA chondrocytes which can produce proinﬂammatory cytokines11.
Many intracellular PRRs like TLR3, TLR7, retinoic acid-inducible
gene 1 (RIG1), dectin1 and NOD-like receptor family CARD
domain containing 3 (NLRC3) are also up-regulated in OA carti-
lage12. Furthermore, TLR3, RIG1 are responsible for the induction of
MMP13 in chondrocytes stimulated with the double-stranded
RNA12, and the NLRC3 inﬂammasome can mediate the patholog-
ical effect of hydroxyapatite crystals in the OA pathogenesis13. But
one of the studies showed that myeloid differentiation 88 (MyD88)
signal is dispensable in medial meniscectomy murine model of
OA14. Although these studies could provide some evidence for the
importance of PRR in OA pathogenesis, the molecular mechanisms
of PRR effects and the regulation about PRR expression in chon-
drocytes are still poorly understood.
There have been several animal and cell models commonly used
for understanding OA pathogenesis. Surgical instability model in
rats or guinea pigs is useful for mimicking the condition of primary
osteoarthritis15, and a low-nutrition diet and T-2 toxin (T-2) intake
by rats can induce the articular cartilage changes very similar to the
pathology found in patients with KBD16e18. KBD is an endemic
osteochondropathy prevailing in north China and T-2 has been
believed as an etiological factor of the disease. In endemic areas,
staple food may contain high levels of T-2, one of the most
important and toxic trichothecene mycotoxins produced by
contaminated Fusarium19. T-2 can reduce the expressions of
gelatin, type II collagen and aggrecan, but enhance the expressions
of MMP-1 and MMP-3 in chondrocytes20. Furthermore, in our
previous study, T-2 can not only enhance the NF-kB activity, which
up-regulates hypoxia-inducible factor 2a (HIF-2a), but also in-
creases the catabolism genes MMP3, MMP9, MMP12 and MMP13
mRNA expressions on hypertrophic chondrocytes21. These results
indicate that abnormal ECM changes induced by T-2 are similar to
the changes of OA and elicit the question whether PPRs are also
involved in the process of T-2 effect on chondrocytes. In this study,
we determined the expressions of common intracellular PPRs in
murine chondrocytes and articular cartilage after T-2 treatment.
And then the roles and signaling pathway of the screened PPR
mediated by T-2 were further identiﬁed in chondrocytes.
Methods
Cell culture
ATDC5 cells (purchased fromECACC)were cultured inDMEM/F12
(1:1, Hyclone) medium with 5% FBS (Hyclone), C28/I2 cells were
cultured in DMEM/F12 (1:1, Hyclone) medium with 10% FBS(Hyclone) at 37C in a humidiﬁed atmosphere of 5% CO2 in air. In T-2
treated experiment, both ATDC5 and C28/I2 cells were seeded at a
density of 1.5  105 per well in 12-well plates overnight, then the
mediumwas replaced by themedium containing 20 ng/mLT-2 for T-
2 group, as well as the conventional medium for control group. For
inducing differentiation of ATDC5 cells, the cellswere cultured in the
induced medium (containing 10 mg/mL human trasferrin, 10 mg/mL
bovine insulin and 3  108 M sodium selenite) by two methods;
monolayer culture and micromass culture. Firstly, ATDC5 cells were
monolayerly cultured in the induced medium for 6 days, then we
transiently transfected with RNAi plasmids separately into the
induced cells, and treated with or without T-2 for the last 24 h. And
then, we used Alcian blue staining to indicate the loss of aggrecan. In
themicromass culture, after ATDC5 cells were transfectedwith RNAi
plasmids, cells were centrifuged and adjusted to 2  107 cell/mL.
Cells (10 mL/wells) were placed at the center of each well for 3 h
before adding the inducedmedium in 24-well plates22; a day before
collected cells were treated with or without T-2. In the inhibitor
treated experiment, BAY11-7085 (ALEXISBiochemicals, USA) andPDTC
(Beyotime, China) were used to treat the cells for 30 min before T-2
treatment. In NAC (SigmaeAldrich, USA) treated experiment, this
reactive oxygen species (ROS) scavenger was used at concentration
of 10 mM to stimulate the cells for 1 h before T-2 treatment.
Construction of shRNA vectors and cell transduction
The short-hairpin RNA (shRNA) Oligos of nod2, tbk1 and ripk2
genes are selected from TRC Library Database, and the details are
given in Table I. The sequence of negative control shRNA is 50-
CCTAAGGTTAAGTCGCCCTCG-30. The shRNA oligos were synthe-
sized by Sangon® Biotech Company. The pLKO.1-TRC plasmid was
used to reconstruct the shRNA plasmids. The integrity of the re-
combinant vectors was conﬁrmed by exploiting DNA sequencing
(GENEWIZ, China). The corrected plasmids were ampliﬁed in Stbl4
bacteria and then extracted by E.Z.N.A.™ Endo-free Plasmid Maxi
Kit (Omega Bio-tec, USA).
All the plasmids were transfected into ATDC5 cells with Lip-
ofectamin™2000 (Invitrogen, USA). Three cell lines expressing
NOD2-shRNA were selected by puromycine (3 mg/mL). The shNC,
shRIPK2 and shTBK1 were transiently transfected into ATDC5 cells,
respectively, and then the cells were treated with 20 ng/mL T-2 in
F12/DMEM medium (FBS free) for 24 h. The supernatant was
collected for the gelatin zymography.
RNA isolation and RT-qPCR
Total RNA from ATDC5 cells was isolated with Trizol® Reagent
(Invitrogen, USA), and cDNA was synthesized by First Strand cDNA
Synthesis Kit (Thermo, Germany) according to the manufacturer's
instructions. RT-qPCR was performed by using iQ5 optical system
software (Bio-Rad Laboratories, USA) with Fast Start Universal SYBR
Green Master (ROX) (Recho, USA) for mRNA quantitation of all
referred genes. The information of all the primers, products and
annealing temperatures is depicted in Table II and the primers of
hprt, tlr3, 7, 8, 9, 11, 12, 13 and col1a1, col2a1, col9a1, col10a1,mmp9,
mmp12, mmp13 were obtained from the literature23e25. Gene
expression analyses were performed against hprt expression and
calculated by using the 2DDCt method.
Protein extraction and Western blotting
Cells were lysed in RIPA solution (Beyotime, China) with a pro-
tease inhibitor PMSF (1 mM). The concentration of total protein was
measuredby BCAassay kit. All the sampleswere separated by 8% SDS
polyacrylamide gel. Proteins were transferred onto a nitrocellulose
Table I
Information of oligos for shRNA plasmids
TRC clone ID Sequence (50-30)
TRCN0000362622 Sh724 Forward CCGGATCTTTGCCTGGAGGATATATCTCGAGATATATCCTCCAGGCAAAGATTTTTTG
Sh724 Reverse AATTCAAAAAATCTTTGCCTGGAGGATATATCTCGAGATATATCCTCCAGGCAAAGAT
TRCN0000362625 Sh2244 Forward CCGGAGCTCTGTATTTGCGAGATAACTCGAGTTATCTCGCAAATACAGAGCTTTTTTG
Sh2244 Reverse AATTCAAAAAAGCTCTGTATTTGCGAGATAACTCGAGTTATCTCGCAAATACAGAGCT
TRCN0000362559 Sh2283 Forward CCGGGGGCACCTGAAGTTGACATTTCTCGAGAAATGTCAACTTCAGGTGCCCTTTTTG
Sh2283 Reverse AATTCAAAAAGGGCACCTGAAGTTGACATTTCTCGAGAAATGTCAACTTCAGGTGCCC
TRCN0000022484 Sh1464 Forward CCGGGCTGCTAGATACGTCTGACATCTCGAGATGTCAGACGTATCTAGCAGCTTTTTG
Sh1464 Reverse AATTCAAAAAGCTGCTAGATACGTCTGACATCTCGAGATGTCAGACGTATCTAGCAGC
TRCN0000027015 Sh435 Forward CCGGCCAGAATCAGAATTTCTCATTCTCGAGAATGAGAAATTCTGATTCTGGTTTTTG
Sh435 Reverse AATTCAAAAACCAGAATCAGAATTTCTCATTCTCGAGAATGAGAAATTCTGATTCTGG
TRCN0000026983 Sh792 Forward CCGGCCTCGGAGGAACAAAGAAGTACTCGAGTACTTCTTTGTTCCTCCGAGGTTTTTG
Sh792 Reverse AATTCAAAAACCTCGGAGGAACAAAGAAGTACTCGAGTACTTCTTTGTTCCTCCGAGG
TRCN0000026954 Sh2222 Forward CCGGGCTGGCCGAGAACAATCATATCTCGAGATATGATTGTTCTCGGCCAGCTTTTTG
Sh2222 Reverse AATTCAAAAAGCTGGCCGAGAACAATCATATCTCGAGATATGATTGTTCTCGGCCAGC
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USA) was used to detected NOD2 protein. Anti-GAPDH antibody
(Abcam, USA) was used to verify the protein concentration. The ECL
system (Thermo, USA) was used to visualize the protein bands.
MTT assay
Cells were incubated with different concentration of T-2 for
24 h, or incubated with 20 ng/mL T-2 for different time, and then
added 10 mL 5 mg/mL of MTT (Solarbio, China) into the wells. The
absorbance at wavelength of 492 nm was measured by multiskan
spectrum (Thermo Electron Corporation, Finland).
Gelatin zymography
Gelatin zymography was performed with 10% SDS-PAGE gels,
which containing 1% 1 mg/mL gelatin. The conditioned medium
was harvested from ATDC5 cells transfected with shRNA of RIPK2,
TBK1 or NC plasmids and stimulated with T-2 for 24 h. Then these
mediums were concentrated by MAXI dry plus machine (Heto-
Holten, Denmark) and quantiﬁed by BCA assay. Firstly, gel elec-
trophoresis was performed. And then the gels were incubated for
two 40 min periods in 200 mL of 50 mmol/L TriseHCl with 2.5%
Triton X-100 and 5 mmol/L CaCl2 (pH 7.4), then washed twice in
50 mmol/L TriseHCl with 5 mmol/L CaCl2 (pH 7.6), and next incu-
bated overnight in 50 mmol/L TriseHCl with 150 mmol/L NaCl,
10 mmol/L CaCl2 and 0.02% NaN3 (pH 7.6) at 37C. In the next
morning, gels were stained with Coomassie Brilliant Blue R250 for
3 h, and destained at room temperature.
Rat experiment and immunohistochemistry
DA rats were bred in a speciﬁc pathogen-free animal house.
Each group contained ﬁve rats at the age of 8e12 weeks. Rats fromTable II
Information of primers for RT-qPCR
Gene accession number Sequence (50-30)
Ripk2 Forward AAATCTGCACCCGAAG
[NM_138952.3] Reverse GGTGACCTCTTCAAAAG
Tbk1 Forward TATCTTTGTCACGAGCC
[NM_019786.4] Reverse AACCAGTTCAACCAGC
Nod1 Forward AAGGGTGAAGCCAAAG
[NM_001171007.1] Reverse TCCATCTCATGATGGCC
Nod2 Forward GTCCTTGGAGGGCTTTG
[NM_145857.2] Reverse CAGACGCCTGGCAGAA
IL-1b Forward CTGTGTCTTTCCCGTGG
[NM_008361.3] Reverse TTGTTGTTCATCTCGGAthe control group were fed with a normal diet; meanwhile rats
from the T-2 group were fed with a normal diet with 300 mg/kg T-2
for 2 months. The experiments were approved by the Institutional
Animal Ethics Committee of the Xi'an Jiaotong University Health
Science Center.
The parafﬁn embedded knee articular cartilage from each rat
was sectioned and immunohistochemistry of NOD2 was per-
formed. All images we took in every section obtained through an
optical microscope (Olympus BX51, Japan) and a digital camera
(Olympus PD71, Japan) should cover the whole structure of the
knee articular cartilage after merging. Five views evenly locating in
each merging images were selected, the mean value of ﬁve views
was considered for the raw result for statistical analysis, and image
with median value was displayed as the representative image by
using Image-Pro Plus6.0 software (Media Cybernetics, USA).
Statistics
Data were expressed in mean ± 95% conﬁdence intervals and
performed by SPSS software. All the data were under normal dis-
tribution analyzed by ShapiroeWilk test. Statistical analysis was
performed by one-way ANOVA among groups, and the Student's t-
test was employed to analyze the signiﬁcant differences between
two groups. The ManneWhitney U test was used to analyze the
density of Western blotting bands. P < 0.05 was considered
signiﬁcant.
Results
The mRNA expressions of anabolism genes decreased and
catabolism genes increased in chondrocytes treated with T-2
We treated ATDC5 cells with 0, 20, 40, 80 ng/mL of T-2 for 24 h
and detected the cellular viability by MTT assay. We found thatProduct size, bp Annealing temperature, C
GAGG 156 60
GCTG
GGG 217 60
CACC
GGTC 166 60
GTG
121 60
T
ACCT 167 60
GCCT
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[Fig. 1(A)]. And when ATDC5 cells were treated with T-2 for 0, 4, 8,
12, 24 h [Fig. 1(B)], the signiﬁcance decrease of cellular viability
could be observed from the twelfth hours. The same results were
also found in the human chondrocyte cell line C28/I2
[Fig. 1(F)e(G)].
We detected mRNA expressions of anabolism genes, col1a1,
col2a1, col9a1, col10a1, and catabolism genes, mmp9, mmp12,
mmp13 by using RT-qPCR. The results showed that compared to
the control group, the anabolism gene expressions signiﬁcantlyFig. 1. The effects of T-2 toxin on chondrocyte cell lines. (A) Effect of different concentratio
reduction for 24 h. (B) Effect of different treatment time (0e24 h) with 20 ng/mL T-2 toxin
expressions of anabolism and catabolism genes in ATDC5 and ATDC5-induced cells treated
concentration (0e80 ng/mL) of T-2 toxin on the cellular viability of C28I/2 cells estimated by
2 toxin on the cellular viability of C28/I2 cell estimated byMTT reduction. (H) The mRNA exp
T-2 toxin for 24 h detected by RT-qPCR. (AeE, H) n ¼ 3 for each group, (FeG) n ¼ 5 for each g
results for statistic. And the values were expressed in mean ± 95% conﬁdence intervals.decreased in the T-2 treated group, whereas the catabolism gene
expressions were induced conspicuously both in the ATDC5 cells
and in the differetiation ATDC5 cells [Fig. 1(C)e(E)]. And when
treating the human chondrocyte cell line C28/I2 with T-2, we
could ﬁnd that the mRNA expressions of col2a1, aggrecan were
decreased signiﬁcantly but the mRNA expression of mmp13 was
up-regulated. [Fig. 1(H)]. These results showed that T-2 not only
impacted the cellular viability on chondrocytes, but also changed
the mRNA expressions of the anabolism and catabolism genes of
the cells.n (0e80 ng/mL) of T-2 toxin on the cellular viability of ATDC5 cells detected by MTT
on the cellular viability of ATDC5 cell estimated by MTT reduction. (CeE) The mRNA
with 0 or 20 ng/mL of T-2 toxin for 24 h detected by RT-qPCR. (F) Effect of different
MTT reduction for 24 h. (G) Effect of different treatment time (0e24 h) with 20 ng/mL T-
ressions of anabolism and catabolism genes in C28/I2 cells treated with 0 or 20 ng/mL of
roup. All the values were gotten from the mean of three separate repeated experiment
J. Xu et al. / Osteoarthritis and Cartilage 23 (2015) 1575e1585 1579Expression of NOD2 signiﬁcantly increased in chondrocytes treated
with T-2
We detected the mRNA expressions of intracellular PRRs that
might involve in the effects of T-2 on ATDC5 cells. The results
showed that only nod2mRNA expression was up-regulated after T-
2 treatment for 8 h [Fig. 2(A)], whereas the mRNA expressions of
other tlrs except tlr3 were not changed. Meanwhile the increased
NOD2 expression maintained until 24 h after T-2 treatmentFig. 2. The expressions of intracellular PPR in chondrocytes and rat articular cartilage treate
with 0 or 20 ng/mL of T-2 toxin for 8 h detected by RT-qPCR. (B) The expression of NOD2 in A
and Western blotting. The density of the NOD2 immune-reactive bands was analyzed by usi
well, by adding Insulin-transferrin-selenium medium to induce the differentiation for 7 days
24 h. The mRNA expression of nod2 in the cells were detected by RT-qPCR. (D) The mRNA ex
were detected by RT-qPCR. (E) The representative immunohistochemical images of NOD2 in
ratio of NOD2 positive cells and total chondrocytes in knee articular cartilage of T-2 toxin trea
All the values were gotten from the mean of three separate repeated experiment results fo[Fig. 2(B)]. And the up-regulation of nod2 could also be obviously
detected in 7 day and 14 day induced ATDC5 cells after treated with
T-2 for 24 h [Fig. 2(C)]. Meanwhile, the mRNA expression of nod2
increased in the C28/I2 cells after T-2 treatment, while the
expression of tlr3 did not change [Fig. 2(D)]. Furthermore, the
NOD2 expression in vivo was veriﬁed, which was increased in the
cartilage of T-2 fed rats [Fig. 2(E)]. These results showed that the
expression of NOD2was increased in chondrocytes treatedwith T-2
in vitro and in vivo.d with T-2 toxin. (A) The mRNA expressions of intracellular PRRs in ATDC5 cells treated
TDC5 cells treated with 20 ng/mL of T-2 toxin for 0, 8, 12 and 24 h detected by RT-qPCR
ng GAPDH expression as a loading control. (C) ATDC5 cells were plated at 2  105 cells/
and 14 days. On the day 6 and day 13, the cells were treated with 20 ng/mL T-2 toxin for
pression of nod2 and tlr3 in C28/I2 cells treated with 0 or 20 ng/mL of T-2 toxin for 8 h
knee articular cartilage from control group rats (a) and T-2 toxin treated rats (b). The
ted rats compared with control rats (n ¼ 5 for each group). (AeD) n ¼ 3 for each group.
r statistic. And the values were expressed in mean ± 95% conﬁdence intervals.
J. Xu et al. / Osteoarthritis and Cartilage 23 (2015) 1575e15851580Intervening NOD2 expression via RNAi could ameliorate detrimental
effects of T-2 on ATDC5 cells
RNAi was applied to determine the effects of up-regulated NOD2
on the expressions of anabolism and catabolismgenes in ATDC5 cells
treated with T-2. Firstly, the detection of NOD2 mRNA and protein
expression showed that sh724-NOD2 could efﬁciently abrogate the
up-regulation of NOD2 induced by T-2 [Fig. 3(A), (B)]. The sh724-
NOD2 ATDC5 cells and the shNC ATDC5 cells were stimulated with
20 ng/mL T-2 for 8 h. The mRNA expressions of col1a1, col2a1
increased signiﬁcantly in the sh724-ATDC5 cells, and that of the
catabolismgenes,mmp9,mmp12 andmmp13, decreased signiﬁcantly
[Fig. 3(C)]. The results indicated that in ATDC5 cells stimulated with
T-2, the up-regulated expression of NOD2 would further inﬂuence
the expression of the cartilaginous metabolism genes.Fig. 3. The effects T-2 toxin on ECM metabolism gene expressions of ATDC5 cells after RNAi
ATDC5 cells treated with 20 ng/mL of T-2 toxin for 8 h detected by RT-qPCR. The sh724-NOD
NOD2 and shNC stably transfected ATDC5 cell detected by Western blotting. Both the sh724
the NOD2 immune-reactive bands was analyzed by using GAPDH expression as a loading con
and shNC stably transfected ATDC5 cells. The cells were treated with 20 ng/mL of T-2 toxin fo
the values were gotten from the mean of three separate repeated experiment results for stThe downstream signal molecules of NOD2 were involved in the
metabolism gene expression in pre- and chondrogenic ATDC5 cells
treated with T-2
ATDC5 cells were transiently transfected with TBK1 shRNA
plasmids and RIPK2 shRNA plasmids separately for 24 h. The RT-
qPCR results showed that shRIPK2 and shTBK1 plasmids effec-
tively down-regulated themRNA expressions of tbk1 and ripk2with
or without T-2 stimulation [Fig. 4(A), (B), (C)]. However, RNAi of
tbk1 or rikp2with shRIPK2 or shTBK1 plasmids could not affect the
up-regulation of nod2 mRNA expression induced by T-2 toxin
[Fig. 4(D)]. Meanwhile, when the TBK1 was down-regulated by
RNAi, the mRNA expressions of mmp9, mmp12 and mmp13
decreased signiﬁcantly, while the mRNA expressions ofmmp12 and
mmp13 decreased when the RIPK2 was knocked down. But theof NOD2 expression. (A) The mRNA expression of nod2 in the stably shRNA transfected
2 plasmid showed the best RNAi efﬁcacy. (B) The protein expression of NOD2 in sh724-
-NOD2 and shNC cells were treated with 20 ng/mL of T-2 toxin for 24 h. The density of
trol. (C) The mRNA expressions of col1a1, col2a1,mmp9,mmp12,mmp13 in sh724-NOD2
r 24 h, and gene expressions were detected by RT-qPCR. (AeC) n ¼ 3 for each group. All
atistic. And the values were expressed in mean ± 95% conﬁdence intervals.
Fig. 4. The effects of T-2 toxin on NOD2 signaling in ATDC5 cells. (A) The mRNA expressions of tbk1 and ripk2 detected by RT-qPCR in ATDC5 cells transiently transfected with
shTBK1 (Sh2222) or shRIPK2 (Sh1464) plasmids separately. (BeE) The mRNA expression of ripk2 (B), tbk1 (C), nod2 (D), col1a1, col2a1, col10a1, mmp9, mmp12 and mmp13. (E) was
detected by RT-qPCR. ATDC5 cells were transiently transfected separately with shNC, shRIPK2 or shTBK plasmids, and then the transfected cells were added with or without 20 ng/
mL T-2 toxin for 24 h. (F) A representative gelatin zymogram (left panel) and density changes (right panel) of serum-free conditioned media from ATDC5 cells with different
treatments. The serum-free conditioned media was derived from ATDC5 cells, which were ﬁrstly transiently transfected with shNC (lanes 1e2), shRIPK2 (lane 3) or shTBK (lane 4)
plasmids, and then the transfected cells were treated with T-2 toxin for 24 h (lanes 2e4). The relative density of the MMP9 and MMP2 reactive bands was analyzed against relative
control band. (AeF) n ¼ 3 for each group. All the values were gotten from the mean of three separate repeated experiment results for statistic. And the values were expressed in
mean ± 95% conﬁdence intervals.
J. Xu et al. / Osteoarthritis and Cartilage 23 (2015) 1575e1585 1581mRNA expressions of the col1a1, col2a1, col10a1 had no difference
when the ripk2 or tbk1 gene was knocked down [Fig. 4(E)].
Furthermore, the gelatin zymography assay of MMP2 and MMP9
showed that the activities of MMP2 and MMP9 were increased
signiﬁcantly in ATDC5 cells stimulated with T-2, whereas theiractivities decreased in the cells transfected with shRIPK2 or shTBK
plasmids [Fig. 4(F)]. We further observed the knockdown effect of
NOD2, RIPK2, and TBK on the proliferatory chondrocytes stimu-
latedwith T-2. The result of alcian blue staining showed that down-
regulating the expressions of nod2, ripk2 or tbk1 could rescue the
J. Xu et al. / Osteoarthritis and Cartilage 23 (2015) 1575e15851582loss of Aggrecan caused by T-2 [Fig. 5(A)]. To conﬁrm the function of
NOD2 signal in these proliferatory chondrocytes, we knocked down
RIPK2 or TBK with shRNA plasmids, then micromass cultured these
transiently transfected cells for 3 days in the induced medium, and
a day before we collected the RNA, the micromass cultured cells
were treatedwith or without T-2. The result showedwhen PIRK2 or
TBK1 was down-regulated by RNAi [Fig. 5(B)], the mRNA expres-
sions ofmmp9,mmp12 andmmp13 decreased signiﬁcantly in the T-
2 treated group, while the mRNA expressions of col2a1 and col10a1
remained at a low pattern [Fig. 5(C)]. It indicated that NOD2
signaling was activated and involved in the expression andFig. 5. The effects of NOD2 signaling in murine chondrocyte treated with T-2 toxin. (A) ATDC
the day 6, the induced ATDC5 cell were transiently transfected separately with shNC, shNOD2
stained in every differently treated chondrocytes. (BeC) ATDC5 cells were transiently tran
insulin-transferrin-selenium medium induced to differentiate for 3 days. On day 3, T-2 to
micromass cultured cells. (C) The mRNA expressions of cola2a1, cola10a1, nod2, mmp9, mmp
group. All the values were gotten from the mean of three separate repeated experiment reactivation of the catabolism genes in ATDC5 and proliferatory
chondrocytes after T-2 treatment.
NF-kB and ROS were involved in the expression of NOD2 in T-2
treated ATDC5 cells
BAY11-7085 and PDTC were chosen as the NF-kB pathway speciﬁc
inhibitors to verify whether the NF-kB activationwas involved in the
up-regulation of NOD2 induced by T-2. BAY11-7085was added into the
ATDC5 cells 30min before T-2 treatment. The result showed that the
mRNA expression of nod2 in the BAY11-7085 pretreated groups at 4, 8,5 cells were monolayer cultured in insulin-transferrin-selenium medium for 7 days. On
, shRIPK2 or shTBK1 plasmids, at the meantime T-2 toxin were added. Alcian blue were
sfected separately with shNC, shRIPK2 or shTBK plasmids and micromass cultured in
xin was added. (B) The mRNA expressions of tbk1 and ripk2 detected by RT-qPCR in
12, mmp13 were detected by RT-qPCR in micromass cultured cells. (AeC) n ¼ 3 for each
sults for statistic. And the values were expressed in mean ± 95% conﬁdence intervals.
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BAY11-7085 [Fig. 6(A)], and the protein expression of NOD2 in the
BAY11-7085 pretreated group also declined compared with that in T-2
group without BAY11-7085 at 24 h [Fig. 6(B)]. PDTC was also admin-
istrated 30 min before adding T-2. The mRNA expression of nod2 in
the PDTCpre-treated group at 8 h declined comparedwith that inT-2
group without PDTC [Fig. 6(C)]. These results demonstrated that the
inhibitors of NF-kB markedly decreased the expression of nod2
induced by T-2 in both mRNA and protein levels. Meanwhile, NAC,
theROS scavenger,wasapplied to the cells 1 hbefore T-2 treatment in
order to observewhetherROSwas involved in the expressionofnod2.
ThemRNA expression of nod2 could be signiﬁcantly inhibited in NAC
pre-treated group [Fig. 6(D)]. These results suggested that T-2 can
quickly increase the ROS production, activate the transcription factor
NF-kB, and then enhance the expression of nod2 in ATDC5 cells.
Discussion
In the present study, we treated the chondrocytes with T-2, and
then screened gene expressions of some intracellular PRRs in the
cells. It was found that NOD2 was involved in the abnormalFig. 6. NF-kB and ROS participation in the dysregulation of NOD2 in ATDC5 cells treated w
pretreated with 5 mM of BAY11-7085 (an inhibitor of IkBa phosphorylation) for 30min before t
NOD2 detected by Western blotting in ATDC5 cells pretreated with 5 mM of BAY11-7085 for
immune-reactive bands was analyzed by using GAPDH expression as a loading control. (C) Th
of PDTC (an antioxidant, inhibitor of NF-kB signaling) for 30 min before the treatment of 20 n
cells pretreated with 10 mM of NAC (N-acetylcysteine, a scavenger of ROS) for 1 h before the
gotten from the mean of three separate repeated experiment results for statistic. And the vmetabolism of ECM after T-2 treatment.We also found that not only
the expression of NOD2 increased, but also NOD2 signal pathway
was activated. And NOD2 expression was regulated by NF-kB and
ROS in the T-2 toxicity to chondrocytes. The observation revealed
the mechanism of NOD2 participating in the metabolism of chon-
drocytes treated with T-2.
According our knowledge, T-2 may involve in the process of
damaged chondrocytes as a perpetrator. So we used this toxin to
stimulate the ATDC5 and C28/I2 cells to investigate the underlying
mechanism in damaging chondrocytes.We utilized the expressions
of anabolic and catabolic genes related with the collagen meta-
bolism to assess the effects on these chondrocytes. Firstly, the cell
viability was detected to choose the optimal concentration and the
time point of T-2 acting on chondrocytes. We found that the inhi-
bition of T-2 on cellular viability showed a dose and time-
dependent tendency consistent with our previous work in hyper-
trophic chondrocytes21 and others work in human chondrocytes26.
Therefore 20 ng/mL of T-2 was selected for further experiments.
The mRNA expressions of anabolism genes, col1a1, col2a1, col9a1
and col10a1 decreased, and the catabolism genes, mmp9, mmp12,
mmp13 increased both in the progenitor and chondrogenicith T-2 toxin. (A) The mRNA expression of nod2 detected by RT-qPCR in ATDC5 cells
he treatment of 20 ng/mL T-2 toxin for 4 h, 8 h, and 24 h. (B) The protein expression of
30 min before the treatment of 20 ng/mL T-2 toxin for 24 h, The density of the NOD2
e mRNA expression of nod2 detected by RT-qPCR in ATDC5 cells pretreated with 10 mM
g/mL T-2 toxin for 8 h. (D) The mRNA expression of nod2 detected by RT-qPCR in ATDC5
treatment of 20 ng/mL T-2 toxin for 8 h (AeD) n ¼ 3 for each group. All the values were
alues were expressed in mean ± 95% conﬁdence intervals.
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sions of col2a1 and aggrecan decreased while mmp13 mRNA
expression increased in C28/I2 cells after T-2 treatment. These re-
sults were similar with observations in human chondrocytes27 and
in murine hypertrophic chondrocytes treated with T-221 and
showed that the disturbed balance of the gene expressions related
to anabolism and catabolism of collagen in chondrocytes actually
was due to T-2. Hence the cells with stimulation of 20 ng/mL T-2
could be used to explore PRR roles in the damages of chondrocytes.
PRRs have been believed to be relatedwith inﬂammatory reaction
in joints. The expression of TLR3 is increased inarticular chondrocytes
treatedwith double-strand RNA12. However, few reports are involved
in PRR function in cartilage biology. And it has been observed that T-2
could induce DNA damage and apoptosis in chondrocytes11,26,28.
Considering theT-2 is a lipid solublemolecular,which caneasilyenter
the cytoplasm,wemainly explore the expression of intracellular PRRs
and their underlying molecular mechanism in the T-2 treated chon-
drocytes. It was found that the expression of NOD2 was specially
increased not only in the murine progenitor, chondrogenic chon-
drocytes and human chondrocyte C28I/2 cells, but also in articular
cartilage of the rats treated with T-2. While the mRNA expression of
tlr3 was decreased only in ATDC5 cells, and other PRRs keep stable
expressions even the chondrocytes were treated with T-2. Consid-
ering the function of NOD2 in recognition of single stranded RNA and
acting as a scaffold for the assembly of large multicomponent
signaling complexes29, the results seem to imply that NOD2 might
work as a key sensor when the cell is damaged by T-2.
For further conﬁrmation of NOD2's effect on T-2 toxicity to
chondrocytes, the speciﬁc RNAi to NOD2 was applied to the cell
model. The mRNA expressions of col1a1, col2a1, il-1b,mmp9,mmp12
and mmp13 were detected to observe whether NOD2 RNAi could
affect the balance of catabolism and anabolism in the cells treated
with T-2. The results showed that when NOD2was down-regulated,
the expression of col1a1 and col2 increased, whereas that of il-1b,
mmp9,mmp12 andmmp13 decreased signiﬁcantly, which presented
strong evidence that NOD2 took part in the chondrocyte ECM
degradation by regulating the expressions of collagen and catabo-
lism genes in the chondrocytes treated with T-2. A recent study also
showed that the NOD2 deﬁciency mice protect from Ag-induced
arthritis characterized by cartilage degradation30, and activated
NOD2 could also promote and exacerbate the inﬂammation in
proteoglycan-induced arthritis mice31,32. In fact, we also found the
expression of NOD2 increased in articular chondrocyte from T-2
treated rats which show similar pathological changes to KBD pa-
tients17. These ﬁndings imply the importance of NOD2 in the carti-
lage damage of arthritis. NOD2 signal also plays a crucial role in
activating pro-il-1b mRNA production and inducing release of
bioactive IL-1b33, which plays important role in OA34. And in our
results, the production of IL-1b could also be regulated by NOD2
RNAi. Therefore NOD2 was considered as a key intracellular PRR in
the damage of chondrocyte model treated with T-2.
The subsequent problem is whether NOD2 signaling pathway is
involved in this process, or how NOD2modulates the expressions of
collagen and catabolism genes in chondrocytes. So in the following
experiment, twoNOD2 signaling adaptors29,35, RIPK2 andTBK1were
knockdowned by RNAi, and then the mRNA expressions of collagen
and catabolism genes, and the activities of MMP2 and MMP9 were
detected. At the same time, we also used alcian blue staining to
indicate the loss of aggrecan in proliferatory chondrocytes. It was
found that the mRNA expression of nod2 still increased after T-2
treated, but the mRNA expression of mmp9, mmp12 and mmp13
declined signiﬁcantly both in the murine progenitor, chondrogenic
chondrocytes, and the activity of MMP2 and MMP9 also decreased
signiﬁcantly after RIPK2 or TBK1 was down-regulated. And the
similar result was also found in myocardial infarction model, inwhich, NOD2 signal could signiﬁcantly increase MMP9 expression
and activity36. These results indicated that elevated NOD2 would
affect the expressions of collagen and catabolism genes, and the
activation of MMP2 and MMP9 through RIPK2 and TBK1.
However, how NOD2 expression was induced in chondrocytes
treated with T-2 is still unclear. In our previous study, it was found
that T-2 could affect hypertrophic chondrocytes through
ROSeNFekBeHIFe2a pathway21. The function of ROS and NF-kB in
chondrocytes is multiple. Did these two molecules play important
roles in regulation of NOD2 expression? To answer this question,
two inhibitors of NF-kB, BAY11-7085, PDTC and NAC, a scavenger of
ROS, were applied to investigate the mechanism of the increasing
expression of NOD2. The results showed that BAY11-7085 could
down-regulate the expression of NOD2 signiﬁcantly, and PDTC or
NAC had the same effect, which implied that the elevated expres-
sion of NOD2might relatewith ROS and activated NF-kB induced by
T-2. The same results are also found in human. For instance, the NF-
kB binding site is critical to regulation of the expression of NOD2
gene37, and ROS are involved in NOD2 signaling in epithelial cells
for protecting the cell against pathogenic bacteria38.
In conclusion, we treated chondrocytes with T-2 and found that
via ROS and NF-kB, T-2 could increase the expression of NOD2. And
then the activated NOD2 signaling could modulate the expression
of MMPs and activate MMP degrading the ECM of chondrocytes.
The ﬁndings not only provide a novel target molecule and pathway
for intervening osteochondral diseases but also shed light on the
molecular mechanism of T-2 on chondrocyte damages.
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